tiprankstipranks
scPharmaceuticals Inc (SCPH)
NASDAQ:SCPH
US Market

scPharmaceuticals (SCPH) Financial Statements

402 Followers

scPharmaceuticals Financial Overview

scPharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.487; its P/E ratio is -2.86; scPharmaceuticals is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 6.10M$ 6.10M$ 3.80M$ 1.64M-
Gross Profit$ 4.32M$ 4.32M$ 2.72M$ 1.64M$ -605.00K
EBIT$ -12.01M$ -11.72M$ -12.49M$ -11.79M$ -10.56M
EBITDA$ -11.96M$ -11.58M$ -12.92M$ -12.04M$ -10.98M
Net Income Common Stockholders$ -14.11M$ -13.81M$ -15.63M$ -14.15M$ -11.21M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 58.40M$ 76.01M$ 90.20M$ 102.88M$ 116.07M
Total Assets$ 78.41M$ 94.48M$ 106.10M$ 114.17M$ 127.32M
Total Debt$ 40.80M$ 40.27M$ 39.81M$ 38.01M$ 37.68M
Net Debt$ -17.60M$ -35.74M$ -50.38M$ -64.86M$ -78.39M
Total Liabilities$ 53.89M$ 57.26M$ 56.95M$ 50.74M$ 51.56M
Stockholders Equity$ 24.52M$ 37.22M$ 49.15M$ 63.43M$ 75.85M
Cash Flow-
Free Cash Flow$ -17.70M$ -15.20M$ -13.45M$ -14.14M$ -16.49M
Operating Cash Flow$ -17.70M$ -15.16M$ -13.45M$ -14.14M$ -16.49M
Investing Cash Flow$ 29.32M$ 26.46M$ -22.93M$ 9.43M$ 7.00M
Financing Cash Flow$ 15.00K$ 467.00K$ 68.00K$ 611.00K$ 13.70M
Currency in USD

scPharmaceuticals Earnings and Revenue History

scPharmaceuticals Debt to Assets

scPharmaceuticals Cash Flow

scPharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis